OneSource Specialty Pharma Limited (BOM:544292)
India flag India · Delayed Price · Currency is INR
1,573.50
-17.75 (-1.12%)
At close: Oct 28, 2026

BOM:544292 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
16,82114,23414,4501,719387.14
Revenue Growth
10.54%-1.49%740.50%344.07%-
Gross Profit
10,6338,9039,484867.0650.71
Operating Income
752.63-36.811,906-1,566-2,164
Net Income
-16.21-738.03-179.71-3,912-7,998
Earnings Per Share
-0.14-6.44-1.63-94.15-200.87
EPS Growth
-----

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '25 Mar '24 Mar '23
India
3,9631,9411,183266.11
Ireland
699.561,750--
United States of America
4,9345,063--
Spain
1,5391,567--
Rest of The World
3,0814,127536.03-
Total
14,21614,4491,719387.14

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
385.68475.162,105222.6494.74
Total Debt
17,54815,0399,4245,7128,642
Net Cash (Debt)
-17,163-14,564-7,319-5,489-8,547
Net Cash Growth
-----
Net Cash Per Share
-149.67-127.17-66.30-132.12-214.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
292.285.23-678.54-1,072-1,628
Capital Expenditures
-4,116-5,691-1,281-637.67-439.95
Free Cash Flow
-3,824-5,605-1,960-1,710-2,068
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
63.21%62.55%65.64%50.43%13.10%
Operating Margin
4.47%-0.26%13.19%-91.09%-558.99%
Pretax Margin
-1.20%-6.46%-4.64%-212.71%-1073.63%
Profit Margin
-0.10%-5.18%-1.24%-227.53%-2066.00%
FCF Margin
-22.73%-39.38%-13.56%-99.45%-534.07%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
10.7611.8613.88--